The Interventional Oncology Center

Filter Your Results




Medtronic’s OsteoCool System Granted Expanded Indication by FDA for the Palliative Treatment of Metastatic Bone Tumors

February 15, 2017 -- Medtronic announced that the US Food and Drug Administration has approved an expanded indication for its OsteoCool RF Ablation System for the palliat…

NCCN Guidelines Recommend SIR-Spheres Y-90 Resin Microspheres to Treat Metastatic Colorectal Cancer

December 12, 2016 -- Sirtex Medical Limited announced that the company's SIR-Spheres yttrium-90 (Y-90) resin microspheres have been included as a category 2A recommended t…

Surefire Medical Receives Grant for Clinical Trial Investigating CAR-T Therapy Delivery Using Precision Infusion System

November 15, 2016 -- Surefire Medical, Inc. has announced that it has received a grant from the Colorado Office of Economic Development and International Trade to commence&nbs…

BTG and Mirada Medical’s Simplicit90Y Dosimetry Software Approved in Europe

October 14, 2016 -- BTG plc and Mirada Medical Ltd. announced European CE Mark certification for Simplicit90Y yttrium-90 (Y-90) dosimetry software. The software is designed to…

Meta-Analysis of Trials Comparing Radioembolization and Chemoembolization for Unresectable HCC Published

October 13, 2016 -- Findings from a systematic review and meta-analysis comparing clinical outcomes of transarterial radioembolization (TARE) versus transarterial chemoemboliz…

Sirtex Microspheres to Be Studied for Cholangiocarcinoma in SIRCCA and Included in ESMO Guidelines

October 11, 2016 -- Sirtex Medical Ltd announced the commencement of SIRCCA (Selective Internal Radiation Therapy [SIRT] in Cholangiocarcinoma), a phase 2 study of the co…

RESIRT Data on Sirtex's SIR-Spheres to Treat Renal Cell Carcinoma Presented at ESMO Congress

October 10, 2016 -- Sirtex Medical Inc. announced that the initial safety and efficacy results from the RESIRT pilot clinical study were presented in a poster session at …

Philips Introduces Next-Generation OncoSuite Interventional Oncology Solution in Europe

September 9, 2016 -- Royal Philips announced that it will unveil the OncoSuite, its next-generation interventional oncology solution, at the CIRSE 2016 annual meetin…



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.